VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
Clinical trial NCT03149575 · TERMINATED
Trial details
- NCT number
- NCT03149575
- Sponsor
- DelMar Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2019-05-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.